Alcon AG | ALC - Operating Expenses

Stock Price
61.40
Daily Change
0.92 1.52%
Monthly
-3.37%
Yearly
-26.75%
Q1 Forecast
60.90

Alcon AG reported $2.28B in Operating Expenses for its fiscal quarter ending in September of 2025.





Operating Expenses Change Date
AstraZeneca USD 16.69B 5.74B Sep/2025
Bayer EUR 10.2B 523M Sep/2025
Essilor EUR 12.02B 308M Jun/2025
Fresenius EUR 4.91B 110M Sep/2025
Fresenius Medical Care EUR 4.43B 73.91M Sep/2025
GlaxoSmithKline GBP 5.76B 203M Sep/2025
GRIFOLS EUR 1.51B 28.3M Sep/2025
Lonza CHF 3.09B 564M Dec/2024
Merck EUR 4.11B 117M Sep/2025
Novartis USD 9.86B 115M Sep/2025
Philips EUR 3.97B 123M Sep/2025
Roche Holding CHF 21.01B 10.84B Dec/2025
Sanofi EUR 10.51B 1.21B Dec/2025
Smith & Nephew USD 2.52B 84M Dec/2025
Sonova Holding CHF 1.52B 59.9M Dec/2025
UCB EUR 2.36B 108M Dec/2024